Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence of Functional Alterations and the Effects of Thyroid Autoimmunity on the Levels of TSH in an Urban Population of Colombia: A Population-Based Study

Author(s): Hernando Vargas-Uricoechea*, Valentina Agredo-Delgado, Hernando David Vargas-Sierra and María V. Pinzón-Fernández

Volume 23, Issue 6, 2023

Published on: 26 December, 2022

Page: [857 - 866] Pages: 10

DOI: 10.2174/1871530323666221128114423

Price: $65

Abstract

Background: The population prevalence of functional alterations and thyroid autoimmunity is high, and numerous genetic and environmental aspects have been described as triggering factors.

Objectives: The objective of this study was to determine the prevalence of functional alterations and thyroid autoimmunity in an urban population of Colombia.

Materials and Methods: It is a cross-sectional, population-based study (n = 9,638) conducted on an urban population of Popayán-Cauca-Colombia between February 5th, 2018, to December 11th, 2021. The variables evaluated were thyrotropin (TSH), free T4 (FT4), and anti-thyroid antibodies (thyroid peroxidase antibodies: TPOAb, and thyroglobulin antibodies: TgAb).

Results: TSH in men was significantly higher than in women. No differences were observed in the values of FT4, TPOAb, and TgAb (according to sex). The prevalence of normal thyroid function and subclinical hypothyroidism was significantly higher in men. The positivity of TPOAb and TgAb was 22.3% and 19.2%, respectively. TSH levels increased with age (both in men and in women). In participants with normal FT4 and negative TPOAb, the TSH was significantly higher. TSH was significantly higher in TPOAb-positive individuals and among those with TPOAb and TgAb positives, as well as in women with positive TPOAb and men with positive TPOAb and TgAb.

Conclusion: In an urban population of Colombia, TSH was found to be higher than in populations of other geographical areas, especially in older individuals and in the presence of positive anti-thyroid antibodies, a high prevalence of functional alterations and thyroid autoimmunity was also found. These findings can be explained by excess iodine consumption and some environmental factors.

Keywords: TSH, thyroid, autoimmunity, TPOAb, TgAb, population-based study.

« Previous Next »
[1]
van der Spoel, E.; Roelfsema, F.; van Heemst, D. Within-person variation in serum thyrotropin concentrations: Main sources, potential underlying biological mechanisms, and clinical implications. Front. Endocrinol., 2021, 12, 619568.
[http://dx.doi.org/10.3389/fendo.2021.619568] [PMID: 33716972]
[2]
Chaker, L.; Razvi, S.; Bensenor, I.M.; Azizi, F.; Pearce, E.N.; Peeters, R.P. Hypothyroidism. Nat. Rev. Dis. Primers, 2022, 8(1), 30.
[http://dx.doi.org/10.1038/s41572-022-00357-7] [PMID: 35589725]
[3]
Feldt-Rasmussen, U.; Effraimidis, G.; Klose, M. The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol. Cell. Endocrinol., 2021, 525, 111173.
[http://dx.doi.org/10.1016/j.mce.2021.111173] [PMID: 33549603]
[4]
Falaschi, P.; Martocchia, A.; Proietti, A.; D’Urso, R.; Gargano, S.; Culasso, F.; Rocco, A. The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: The impact of the negative feedback mechanism. Neuroendocrinol. Lett., 2004, 25(4), 292-296.
[PMID: 15361820]
[5]
Walsh, J.P. Thyroid function across the lifespan: Do age-related changes matter? Endocrinol. Metab., 2022, 37(2), 208-219.
[http://dx.doi.org/10.3803/EnM.2022.1463] [PMID: 35417936]
[6]
Ma, C.; Cheng, X.; Xue, F.; Li, X.; Yin, Y.; Wu, J.; Xia, L.; Guo, X.; Hu, Y.; Qiu, L.; Xu, T. Validation of an approach using only patient big data from clinical laboratories to establish reference intervals for thyroid hormones based on data mining. Clin. Biochem., 2020, 80, 25-30.
[http://dx.doi.org/10.1016/j.clinbiochem.2020.03.012] [PMID: 32199936]
[7]
Thyroid function tests: Thyroid disease: Assessment and management. In: National Guideline Centre (UK); National Institute for Health and Care Excellence (NICE): London, 2019.
[8]
Vanderpump, M.P.J. The epidemiology of thyroid disease. Br. Med. Bull., 2011, 99(1), 39-51.
[http://dx.doi.org/10.1093/bmb/ldr030] [PMID: 21893493]
[9]
Antonelli, A.; Ferrari, S.M.; Corrado, A.; Di Domenicantonio, A.; Fallahi, P. Autoimmune thyroid disorders. Autoimmun. Rev., 2015, 14(2), 174-180.
[http://dx.doi.org/10.1016/j.autrev.2014.10.016] [PMID: 25461470]
[10]
Ragusa, F.; Fallahi, P.; Elia, G.; Gonnella, D.; Paparo, S.R.; Giusti, C.; Churilov, L.P.; Ferrari, S.M.; Antonelli, A. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract. Res. Clin. Endocrinol. Metab., 2019, 33(6), 101367.
[http://dx.doi.org/10.1016/j.beem.2019.101367] [PMID: 31812326]
[11]
Weetman, A.P. An update on the pathogenesis of Hashimoto’s thyroiditis. J. Endocrinol. Invest., 2021, 44(5), 883-890.
[http://dx.doi.org/10.1007/s40618-020-01477-1] [PMID: 33332019]
[12]
Rayman, M.P. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc. Nutr. Soc., 2019, 78(1), 34-44.
[http://dx.doi.org/10.1017/S0029665118001192] [PMID: 30208979]
[13]
Garmendia Madariaga, A.; Santos Palacios, S.; Guillén-Grima, F.; Galofré, J.C. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J. Clin. Endocrinol. Metab., 2014, 99(3), 923-931.
[http://dx.doi.org/10.1210/jc.2013-2409] [PMID: 24423323]
[14]
Vargas-Uricoechea, H.; Pinzón-Fernández, M.V.; Bastidas-Sánchez, B.E.; Jojoa-Tobar, E.; Ramírez-Bejarano, L.E.; Murillo-Palacios, J. Iodine status in the colombian population and the impact of universal salt iodization: A double-edged sword? J. Nutr. Metab., 2019, 2019, 1-10.
[http://dx.doi.org/10.1155/2019/6239243] [PMID: 31061736]
[15]
Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion
[16]
Hollowell, J.G.; Staehling, N.W.; Flanders, W.D.; Hannon, W.H.; Gunter, E.W.; Spencer, C.A.; Braverman, L.E. Serum TSH, T 4, and thyroid antibodies in the United States population (1988 to 1994): National health and nutrition examination survey (NHANES III). J. Clin. Endocrinol. Metab., 2002, 87(2), 489-499.
[http://dx.doi.org/10.1210/jcem.87.2.8182] [PMID: 11836274]
[17]
Raverot, V.; Bonjour, M.; Abeillon du Payrat, J.; Perrin, P.; Roucher-Boulez, F.; Lasolle, H.; Subtil, F.; Borson-Chazot, F. Age- and sex-specific TSH upper-limit reference intervals in the general french population: There is a need to adjust our actual practices. J. Clin. Med., 2020, 9(3), 792.
[http://dx.doi.org/10.3390/jcm9030792] [PMID: 32183257]
[18]
Wang, X.; Li, Y.; Zhai, X.; Wang, H.; Zhang, F.; Gao, X.; Liu, S.; Teng, W.; Shan, Z. Reference intervals for serum thyroid-stimulating hormone based on a recent nationwide cross-sectional study and meta-analysis. Front. Endocrinol., 2021, 12, 660277.
[http://dx.doi.org/10.3389/fendo.2021.660277] [PMID: 34140930]
[19]
Vargas-Uricoechea, H.; Mera-Mamian, A.; Bastidas-Sanchez, B.; Pinzon-Fernandez, M.; Murillo-Palacios, J.; Ramirez-Bejarano, L. Population status of iodine and its potential effects on thyroid function and autoimmunity in Southwestern Colombia. J. Clin. Med. Res., 2022, 14(3), 126-135.
[http://dx.doi.org/10.14740/jocmr4689] [PMID: 35464607]
[20]
Guastamacchia, E.; Giagulli, V.; Licchelli, B.; Triggiani, V. Selenium and iodine in autoimmune Thyroiditis. Endocr. Metab. Immune Disord. Drug Targets, 2015, 15(4), 288-292.
[http://dx.doi.org/10.2174/1871530315666150619094242] [PMID: 26088475]
[21]
Benvenga, S.; Elia, G.; Ragusa, F.; Paparo, S.R.; Sturniolo, M.M.; Ferrari, S.M.; Antonelli, A.; Fallahi, P. Endocrine disruptors and thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab., 2020, 34(1), 101377.
[http://dx.doi.org/10.1016/j.beem.2020.101377] [PMID: 32081544]
[22]
Lee, H.J.; Li, C.W.; Hammerstad, S.S.; Stefan, M.; Tomer, Y. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J. Autoimmun., 2015, 64, 82-90.
[http://dx.doi.org/10.1016/j.jaut.2015.07.009] [PMID: 26235382]
[23]
Lee, H.J.; Stefan-Lifshitz, M.; Li, C.W.; Tomer, Y. Genetics and epigenetics of autoimmune thyroid diseases: Translational implications. Best Pract. Res. Clin. Endocrinol. Metab., 2022, 2022, 101661.
[http://dx.doi.org/10.1016/j.beem.2022.101661] [PMID: 35459628]
[24]
Teti, C.; Panciroli, M.; Nazzari, E.; Pesce, G.; Mariotti, S.; Olivieri, A.; Bagnasco, M. Iodoprophylaxis and thyroid autoimmunity: An update. Immunol. Res., 2021, 69(2), 129-138.
[http://dx.doi.org/10.1007/s12026-021-09192-6] [PMID: 33914231]
[25]
Pitto, L.; Gorini, F.; Bianchi, F.; Guzzolino, E. New insights into mechanisms of endocrine-disrupting chemicals in Thyroid diseases: The epigenetic way. Int. J. Environ. Res. Public Health, 2020, 17(21), 7787.
[http://dx.doi.org/10.3390/ijerph17217787] [PMID: 33114343]
[26]
Gong, B.; Wang, C.; Meng, F.; Wang, H.; Song, B.; Yang, Y.; Shan, Z. Association between gut microbiota and autoimmune thyroid disease: A systematic review and meta-analysis. Front. Endocrinol., 2021, 12, 774362.
[http://dx.doi.org/10.3389/fendo.2021.774362] [PMID: 34867823]
[27]
Hernando, V.U.; Andry, M.M.; María Virginia, P.F.; Valentina, A. Vitamin D nutritional status in the adult population in Colombia – An analytical cross-sectional study. Heliyon, 2020, 6(2), e03479.
[http://dx.doi.org/10.1016/j.heliyon.2020.e03479] [PMID: 32140595]
[28]
Galușca, D.; Popoviciu, M.S.; Babeș, E.E.; Vidican, M.; Zaha, A.A.; Babeș, V.V.; Jurca, A.D.; Zaha, D.C.; Bodog, F.; Vitamin, D. Vitamin D implications and effect of supplementation in endocrine disorders: Autoimmune thyroid disorders (hashimoto’s disease and grave’s disease), diabetes mellitus and obesity. Medicina, 2022, 58(2), 194.
[http://dx.doi.org/10.3390/medicina58020194] [PMID: 35208518]
[29]
Valladales-Restrepo, L.F.; Correa-Sánchez, Y.; Aristizábal-Carmona, B.S.; Machado-Alba, J.E. Treatment regimens used in the management of Helicobacter pylori in Colombia. Braz. J. Infect. Dis., 2022, 26(1), 102331.
[http://dx.doi.org/10.1016/j.bjid.2022.102331] [PMID: 35182470]
[30]
Hou, Y.; Sun, W.; Zhang, C.; Wang, T.; Guo, X.; Wu, L.; Qin, L.; Liu, T. Meta-analysis of the correlation between Helicobacter pylori infection and autoimmune thyroid diseases. Oncotarget, 2017, 8(70), 115691-115700.
[http://dx.doi.org/10.18632/oncotarget.22929] [PMID: 29383192]
[31]
Fröhlich, E.; Wahl, R. Thyroid autoimmunity: Role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front. Immunol., 2017, 8, 521.
[http://dx.doi.org/10.3389/fimmu.2017.00521] [PMID: 28536577]
[32]
Walsh, J.P.; Bremner, A.P.; Feddema, P.; Leedman, P.J.; Brown, S.J.; O’Leary, P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: A 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J. Clin. Endocrinol. Metab., 2010, 95(3), 1095-1104.
[http://dx.doi.org/10.1210/jc.2009-1977] [PMID: 20097710]
[33]
Karimi, F.; Kalantarhormozi, M.R.; Dabbaghmanesh, M.H.; Ranjbar Omrani, G. Thyroid disorders and the prevalence of antithyroid antibodies in Shiraz population. Arch. Iran Med., 2014, 17(5), 347-351.
[PMID: 24784864]
[34]
Bogusławska, J.; Godlewska, M.; Gajda, E.; Piekiełko-Witkowska, A. Cellular and molecular basis of thyroid autoimmunity. Eur. Thyroid J., 2022, 11(1), e210024.
[http://dx.doi.org/10.1530/ETJ-21-0024] [PMID: 34981746]
[35]
O’Leary, P.C.; Feddema, P.H.; Michelangeli, V.P.; Leedman, P.J.; Chew, G.T.; Knuiman, M.; Kaye, J.; Walsh, J.P. Investigations of thyroid hormones and antibodies based on a community health survey: The Busselton thyroid study. Clin. Endocrinol., 2006, 64(1), 97-104.
[http://dx.doi.org/10.1111/j.1365-2265.2005.02424.x] [PMID: 16402936]
[36]
Li, Y.; Teng, D.; Guan, H.; Li, Y.; Teng, X.; Yu, X.; Mao, J.; Shi, X.; Fan, C.; Shan, Z.; Teng, W. Dynamic changes in antithyroperoxidase and antithyroglobulin antibodies suggest an increased risk for abnormal thyrotropin levels. Front. Endocrinol., 2020, 11, 521.
[http://dx.doi.org/10.3389/fendo.2020.00521] [PMID: 32849304]

Rights & Permissions Print Cite
Article Metrics
18
2
© 2024 Bentham Science Publishers | Privacy Policy